Dataset from A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/PR00007578
下载链接
链接失效反馈官方服务：
资源简介：
The main purpose of this study is to evaluate the safety and efficacy of the study drug known
as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) naïve participants
with nonradiographic axial spondyloarthritis (nonrad-axSpA).
创建时间：
2025-10-02
